Only 60 million shares, and it's baked into the price?
Let's agree to disagree. I believe the market will keep it near 15 cents until IDE.
This is exactly why I would moan about running out of funds because of needless spending on IsoPet. We would have been much better off, imo, if we had zero additional vet clinics opened and zero IsoPet effort outside support for RadioGel over the past 2+ years. Likely, we could have made it here without that last need for capital raise (maybe last 2), then they could have waited for IDE approval, see where stock price is after IDE, and sell fewer shares at a higher price than what we have to sell for now at that time.
Everyone keeps talking about buy-out by BP. A buyout for a company at 5 billion dollars for a company with 380 million shares is $13/share. Same buyout for a company with 480 million shares is $10/share. You have done nicely either way...but one needs these kinds of buyout levels for impact to be minimal.
It is hard to keep spirits up while seeing the price action lately. One can try to focus on the company's target of treating all solid cancerous tumors - it is certainly possible they get there ($5B bouout). I would even say probable if IDE is approved and our 1st clinical trials go well.
✌️ Waiting for 🚀 but until then it's 🤷🏻♂️🤯😳😞. Hopefully once IDE is approved we will all 💣💥🚀🤩🎉🎊🍾🍺🍺🤑🤑🤌🍾🍾🍾🎉🎉🍾🍾
News 
Market Data 
Discover 
